← All companies
Dyne Therapeutics, Inc.
DYN - CIK 0001818794
Market cap$2.92 B
Rank#1827
SEC filings710
The table below shows Dyne Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $753.10M | $573.61M | $485.04M | $472.25M | $532.16M | $608.20M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.